Skip to main content
https://pbs.twimg.com/media/F2iAGXfWwAA96Hd.jpg
High mortality risk predictors in patients with anti-MDA5 dermatomyositis include: - rapidly progressive interstitial lung disease - anti-Ro52 antibody - age > 57 years (based on study of 126 MDA-5+ DM pts) https://t.co/VCyLhStFgX https://t.co/y3CyzOlwDt
Dr. John Cush
02-08-2023
×